58,742 Shares in Synopsys, Inc. $SNPS Purchased by Munich Reinsurance Co Stock Corp in Munich

Munich Reinsurance Co Stock Corp in Munich acquired a new position in shares of Synopsys, Inc. (NASDAQ:SNPS) during the 3rd quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The fund acquired 58,742 shares of the semiconductor company’s stock, valued at approximately $28,983,000.

Other hedge funds and other institutional investors have also added to or reduced their stakes in the company. Stanley Laman Group Ltd. increased its position in shares of Synopsys by 542.9% during the 3rd quarter. Stanley Laman Group Ltd. now owns 12,877 shares of the semiconductor company’s stock valued at $6,353,000 after purchasing an additional 10,874 shares during the last quarter. Symphony Financial Ltd. Co. boosted its stake in Synopsys by 4,780.9% during the second quarter. Symphony Financial Ltd. Co. now owns 40,219 shares of the semiconductor company’s stock worth $20,638,000 after buying an additional 39,395 shares during the period. Empirical Asset Management LLC purchased a new position in Synopsys during the third quarter worth $773,000. Strategic Advisors LLC increased its position in Synopsys by 76.3% during the third quarter. Strategic Advisors LLC now owns 7,578 shares of the semiconductor company’s stock valued at $3,739,000 after acquiring an additional 3,279 shares during the last quarter. Finally, Napean Trading & Investment Co Singapore PTE Ltd increased its position in Synopsys by 17.6% during the second quarter. Napean Trading & Investment Co Singapore PTE Ltd now owns 23,683 shares of the semiconductor company’s stock valued at $12,142,000 after acquiring an additional 3,544 shares during the last quarter. 85.47% of the stock is currently owned by hedge funds and other institutional investors.

Synopsys Stock Down 1.1%

Shares of NASDAQ:SNPS opened at $437.41 on Friday. The business’s 50 day moving average is $466.71 and its 200 day moving average is $470.69. The stock has a market cap of $83.79 billion, a P/E ratio of 67.92, a price-to-earnings-growth ratio of 3.60 and a beta of 1.15. Synopsys, Inc. has a 52-week low of $365.74 and a 52-week high of $651.73. The company has a quick ratio of 1.26, a current ratio of 1.36 and a debt-to-equity ratio of 0.33.

Synopsys (NASDAQ:SNPS) last issued its earnings results on Wednesday, February 25th. The semiconductor company reported $3.77 earnings per share for the quarter, topping the consensus estimate of $3.56 by $0.21. Synopsys had a return on equity of 6.83% and a net margin of 13.76%.The business had revenue of $2.41 billion during the quarter, compared to analysts’ expectations of $2.39 billion. During the same period in the prior year, the business earned $3.03 EPS. The business’s revenue for the quarter was up 65.6% compared to the same quarter last year. Synopsys has set its FY 2026 guidance at 14.380-14.460 EPS and its Q2 2026 guidance at 3.110-3.170 EPS. Sell-side analysts predict that Synopsys, Inc. will post 10.64 EPS for the current year.

Analysts Set New Price Targets

Several equities research analysts have recently issued reports on SNPS shares. Bank of America upgraded shares of Synopsys from an “underperform” rating to a “neutral” rating and lowered their target price for the stock from $525.00 to $500.00 in a report on Monday, December 8th. Zacks Research upgraded shares of Synopsys from a “strong sell” rating to a “hold” rating in a report on Monday, November 10th. Needham & Company LLC reissued a “buy” rating on shares of Synopsys in a research report on Thursday, February 26th. Rosenblatt Securities decreased their price objective on shares of Synopsys from $560.00 to $530.00 and set a “buy” rating for the company in a research note on Thursday, February 26th. Finally, Citigroup initiated coverage on Synopsys in a research report on Monday, November 24th. They set a “buy” rating and a $580.00 target price for the company. Eight analysts have rated the stock with a Buy rating, eight have issued a Hold rating and one has assigned a Sell rating to the stock. According to MarketBeat.com, the stock has an average rating of “Hold” and an average target price of $531.00.

Insider Activity

In other Synopsys news, insider Janet Lee sold 250 shares of the firm’s stock in a transaction dated Monday, January 12th. The shares were sold at an average price of $530.00, for a total transaction of $132,500.00. Following the transaction, the insider owned 11,959 shares of the company’s stock, valued at approximately $6,338,270. This trade represents a 2.05% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is available at this hyperlink. Also, CFO Shelagh Glaser sold 3,657 shares of the company’s stock in a transaction that occurred on Friday, December 19th. The stock was sold at an average price of $460.77, for a total transaction of $1,685,035.89. Following the completion of the sale, the chief financial officer directly owned 17,842 shares of the company’s stock, valued at $8,221,058.34. The trade was a 17.01% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Over the last quarter, insiders have sold 4,157 shares of company stock worth $1,945,036. 0.56% of the stock is owned by company insiders.

Synopsys Profile

Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.

In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.